Welcome to CDC stacks | In Vivo Time-gated Fluorescence Imaging with Biodegradable Luminescent Porous Silicon Nanoparticles - 30102 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
In Vivo Time-gated Fluorescence Imaging with Biodegradable Luminescent Porous Silicon Nanoparticles
Filetype[PDF-498.50 KB]


Details:
  • Personal Authors:
  • Keywords:
  • Pubmed ID:
    23933660
  • Pubmed Central ID:
    PMC4154512
  • Description:
    Fluorescence imaging is one of the most versatile and widely used visualization methods in biomedical research. However, tissue autofluorescence is a major obstacle confounding interpretation of in vivo fluorescence images. The unusually long emission lifetime (5-13 μs) of photoluminescent porous silicon nanoparticles can allow the time-gated imaging of tissues in vivo, completely eliminating shorter-lived (<10 ns) emission signals from organic chromophores or tissue autofluorescence. Here using a conventional animal imaging system not optimized for such long-lived excited states, we demonstrate improvement of signal to background contrast ratio by >50-fold in vitro and by >20-fold in vivo when imaging porous silicon nanoparticles. Time-gated imaging of porous silicon nanoparticles accumulated in a human ovarian cancer xenograft following intravenous injection is demonstrated in a live mouse. The potential for multiplexing of images in the time domain by using separate porous silicon nanoparticles engineered with different excited state lifetimes is discussed.

  • Document Type:
    Journal Article
  • Collection(s):
    CDC Public Access
  • Funding:
    1DP20D006499-01/DP/NCCDPHP CDC HHS/United States
    5-R01-CA124427/CA/NCI NIH HHS/United States
    5R01EB015498/EB/NIBIB NIH HHS/United States
    CA095298/CA/NCI NIH HHS/United States
    CA152185/CA/NCI NIH HHS/United States
    DP2 OD006499/OD/NIH HHS/United States
    HHMI56005681/Howard Hughes Medical Institute/United States
    P50 CA128346/CA/NCI NIH HHS/United States
    P50CA128346/CA/NCI NIH HHS/United States
    R01 CA095298/CA/NCI NIH HHS/United States
    R01 CA124427/CA/NCI NIH HHS/United States
    R01 CA152185/CA/NCI NIH HHS/United States
    R01 EB015498/EB/NIBIB NIH HHS/United States
    U54 CA119335/CA/NCI NIH HHS/United States
    U54-CA 119335/CA/NCI NIH HHS/United States
    Howard Hughes Medical Institute/United States
No Related Documents.
You May Also Like:
  1. Versatile FRET-Based Mesoporous Silica Nanoparticles for Real-Time Monitoring of Drug Release
    Personal Author:
    Lai, Jinping; Shah, Birju P.; Garfunkel, Eric; Lee, Ki-Bum;
    Published:
    Mar 11 2013
    Source:
    ACS Nano. 7(3):2741-2750.
    Description:
    We describe the development of a versatile fluorescence resonance energy transfer (FRET)-based real-time monitoring system, consisting of (a) coumarin-labeled-cysteine tethered mesoporous silica nanoparticles (MSNs) as the drug carrier, (b) a fluores...
    File Type:
    Filetype[PDF - 1.99 MB]
  2. Engineering nanomedicines using stimuli-responsive biomaterials
    Personal Author:
    Wang, Yapei; Byrne, James D.; Napier, Mary E.; DeSimone, Joseph M.;
    Published:
    Jan 14 2012
    Source:
    Adv Drug Deliv Rev. 2011; 64(11):1021-1030.
    Description:
    The ability to engineer particles has the potential to shift the paradigm in the creation of new medicines and diagnostics. Complete control over particle characteristics, such as size, shape, mechanical property, and surface chemistry, can enable ra...
    File Type:
    Filetype[PDF - 4.16 MB]
  3. The impact of UVB exposure and differentiation state of primary keratinocytes on their interaction with quantum dots
    Personal Author:
    Mortensen, Luke J.; Ravichandran, Supriya; DeLouise, Lisa A.;
    Published:
    Oct 25 2012
    Source:
    Nanotoxicology. 2012; 7:1244-1254.
    Description:
    In this study we utilised an in vitro model system to gain insight into the potential cellular interactions that quantum dot (QD) nanoparticles may experience while transiting the viable skin epidermis, and we consider the effects of UVB exposure. UV...
    File Type:
    Filetype[PDF - 1.21 MB]
  4. Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT Nanoparticles
    Personal Author:
    Parrott, Matthew C.; Finniss, Mathew; Luft, J. Chris; Pandya, Ashish; Gullapalli, Anuradha; Napier, Mary E.; DeSimone, Joseph M.;
    Published:
    Apr 30 2012
    Source:
    J Am Chem Soc. 134(18):7978-7982.
    Description:
    Asymmetric bifunctional silyl ether (ABS) prodrugs of chemotherapeutics were synthesized and incorporated within 200 nm × 200 nm particles. ABS prodrugs of gemcitabine were selected as model compounds because of the difficulty to encapsulate a water...
    File Type:
    Filetype[PDF - 1.59 MB]
  5. Nanotopography-mediated Reverse Uptake for siRNA Delivery into Neural Stem Cells to Enhance Neuronal Differentiation
    Personal Author:
    Solanki, Aniruddh; Shah, Shreyas; Yin, Perry T.; Lee, Ki-Bum;
    Published:
    2013
    Source:
    Sci Rep. 2013; 3.
    Description:
    RNA interference (RNAi) for controlling gene expression levels using siRNA or miRNA is emerging as an important tool in stem cell biology. However, the conventional methods used to deliver siRNA into stem cells result in significant cytotoxicity and ...
    File Type:
    Filetype[PDF - 1.22 MB]